BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$8.97
+3.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.30x
- Price / sales
- 3.16x
- Price / cash flow
- -50.49x
Enterprise value
- Enterprise value
- $110.9M
- EV / sales
- 2.93x
- EV / EBITDA
- -9.98x
- EV / EBIT
- -8.82x
- Market cap
- $119.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026